A
Aria CV
Health Tech & Medtech · Saint Paul, United States · Founded 2010
Developing a medical device designed to improve the lives of patients living with the disease of Pulmonary Arterial Hypertension MoreLess
Aria CV is a medical device company focused on developing a novel implantable device designed to treat pulmonary hypertension (PH). The company's core product is an elegant device that operates without batteries, pumps, or electronics, relying entirely on the motion of the heart. This device consists of four simple components: a reservoir, a balloon, a narrow conduit allowing gas movement, and a nitinol anchor that holds the balloon in place. Aria CV primarily serves patients suffering from pulmonary hypertension, a condition characterized by high blood pressure in the lungs' arteries, which can lead to heart failure if untreated. The company operates in the medical device market, targeting healthcare providers and institutions involved in treating PH. Aria CV's business model revolves around clinical trials and investigational use, aiming to gain regulatory approval for widespread adoption. Revenue generation is expected through the commercialization of the device post-approval, focusing on partnerships with healthcare providers and direct sales to medical institutions.
Keywords: pulmonary hypertension, implantable device, medical innovation, heart-driven, clinical trials, healthcare providers, regulatory approval, nitinol anchor, gas conduit, investigational use.
Company overview
Aria CV company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2010
- Headquarters
- Saint Paul, United States
- Employees
- 10
- Open positions
- None listed
- Dealroom signal
- 64.6
Valuation & funding
Aria CV funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| LATE VCOther financing | Jul 2022 | $13M | $155M | Undisclosed | ↗ |
| SERIES BOther financing | Feb 2020 | $31M | $124M | Catalyst Health Ventures · Longview Ventures · BioStar Capital · Cedar Point Capital | ↗ |
| EARLY VCOther financing | Mar 2018 | $1.9M | $7.6M | Undisclosed | — |
| SERIES AOther financing | Jul 2015 | $7.8M | $31M | Broadview Ventures · Catalyst Health Ventures · BioStar Capital · Catalyst Health Ventures | — |
| SPINOUTOther financing | May 2011 | $0 | — | University of Minnesota Twin Cities | — |
Growth signals
Aria CV website traffic
Latest recorded traffic for Aria CV is 730 monthly website visits, down 15.1% over the last three months. Aria CV's team declined 28.6% over the past year.
Comparisons
Aria CV compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
Aria CV's talent
Source: Dealroom Talent Intelligence.
Investors
7 investors on Aria CV's cap table
Sourced from Dealroom's funding and investor records.






Global footprint
Where Aria CV has talent and traffic
team presence
In the news
Latest news about Aria CV
Recent press, funding announcements, and product moves mentioning Aria CV — open to read from the original sources.
Market sentiment
What the market is saying about Aria CV
An AI-synthesized read of the highest-engagement posts about Aria CV on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Aria CV’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







